Field Epidemiology · Diagnostic Strategy Lab

Malaria Diagnostics &
Screening Strategy

Bayesian performance, test operating characteristics, and the cost of missed cases
Tests in Use
● RDT (HRP2/pLDH)
● Microscopy (thick film)
● PCR (nested/qPCR)
Pop. = 10,000 persons
1,000 simulated screens
⚕ The same test sensitivity and specificity produce very different predictive values depending on background prevalence. Adjust prevalence, test characteristics, and screening strategy to observe how the surveillance pyramid changes — and how missed sub-patent infections sustain transmission.
Diagnostic Test
Test Characteristics
Sensitivity (Se) P(T+ | Disease+) 92%
Specificity (Sp) P(T− | Disease−) 97%
Sub-patent detection Sensitivity for low-density infections 10%
Epidemiological Setting
True prevalence Including sub-patent infections 10%
Sub-patent fraction Of all true infections 30%
Screening Strategy
Population coverage Fraction screened/treated 80%
Cost per treatment (ACT) USD $2.5
Operating Metrics
PPV
pos. pred. value
NPV
neg. pred. value
Missed cases
per 10,000
False treats
per 10,000
NNS
need to screen
Total cost
per 10,000 pop.
Programme Cost Breakdown
Testing
True-positive treatment
False-positive treatment
Total
Confusion Matrix
Fig. I · N = 10,000
Test Positive
Test Negative
Disease +
Disease −
True Positive
Detected & treated
False Negative
Missed — reservoir
False Positive
Unnecessary Rx
True Negative
Correctly cleared
Adjust prevalence and test characteristics to observe how the cell counts shift.
PPV & NPV across Prevalence
Fig. II · Bayesian sweep
The vertical line marks the current prevalence. PPV collapses at low prevalence even with high sensitivity — the core Bayesian insight.
Test Comparison — ROC
Fig. III
Each test's operating point on the ROC plane. PCR dominates; microscopy and RDT trade sensitivity for cost.
Missed Cases vs Prevalence
Fig. IV
Missed infections per 10,000 screened. Sub-patent reservoir is invisible to RDT and microscopy.
Surveillance Pyramid & Transmission Reservoir
Fig. V
Stacked bar showing the fate of all true infections under the current screening strategy. Missed sub-patent infections sustain onward transmission.
Field Interpretation
Adjust parameters to generate interpretation.

Bayesian Diagnostic Equations

PPV = Se·P / [Se·P + (1−Sp)·(1−P)]
NPV = Sp·(1−P) / [Sp·(1−P) + (1−Se)·P]
TP = N·P·[Se_patent·(1−f_sub) + Se_sub·f_sub]
FN = N·P − TP    LR+ = Se/(1−Sp)
P=prevalence · f_sub=sub-patent fraction · Se_sub=sub-patent sensitivity